Hajime Senjo

10PUBLICATIONS
28CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical virologyPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 24, 2026
Early administration of calcineurin inhibitors limits tolerogenic effect of PTCy in allogeneic hematopoietic transplant.

|Jun 21, 2024
GVHD targets organoid-forming bile duct stem cells in a TGF-β-dependent manner.

Yuta Hasegawa, Daigo Hashimoto, Zixuan Zhang

|Jul 06, 2023
Booster effect of a third mRNA-based COVID-19 vaccine dose in patients with myeloid malignancies.

Akio Mori, Masahiro Onozawa, Mirei Kobayashi

|May 22, 2023
Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT.

Hajime Senjo, Shinpei Harada, Shimpei I Kubota

|Mar 02, 2023
Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms.

Mirei Kobayashi, Akio Mori, Masahiro Onozawa

|Nov 28, 2022
Humoral response to mRNA-based COVID-19 vaccine in patients with immune thrombocytopenia.

Akio Mori, Masahiro Onozawa, Mirei Kobayashi

Pageof 2

Frequent Collaborators

7 joint publications

Takanori Teshima

5 joint publications

Daigo Hashimoto

5 joint publications

Takahide Ara

4 joint publications

Yuta Hasegawa